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Humoral  and  cellular mechanisms  have been  implicated  in  the  pathogenesis of 
acute renal allograft rejection in man  (1, 2). Regardless of the relative role of either 
process in individual patients, the dominant  histopathologic lesion is one of mono- 
nuclear cell infiltration of the interstitium. Investigations of this lesion have focused 
on  analysis  of tissue  sections by  light  and  electron  microscopy and  on  functional 
characteristics of cell suspensions derived from rejected tissue (3-5). 
Monoclonal antibodies have been developed that  identify antigens  expressed on 
functionally defined sets  of mononuclear cells.  Recently, these reagents  have been 
used  to  determine the  location and  quantity  of mononuclear cells of thymus  (6), 
lymph node  (7), bone marrow (8), and tonsil  (9).  In the present study, we used six 
hybridoma-derived  monoclonal  antibodies  that  recognize T  cells  (10,  11),  T  cell 
subsets  (12,  13),  B  cells  (14),  and  monocytes and  null  cells  (15)  to  investigate the 
mononuclear cell populations of tissue from renal grafts undergoing rejection. Double- 
layer  immunofluorescent  enhancement  and  fluorochrome  staining  of nuclei  (16) 
permitted localization and enumeration of reactive and  nonreactive cells in  frozen 
tissue  sections.  This  analysis  has  demonstrated  a  pattern  of cellular  infiltration 
characteristic of renal transplant rejection. 
Materials and Methods 
Source of Tissue and Blood.  33 renal tissues were obtained from 31 patients:  22 grafts with 
interstitial  rejection  (IR), 1 6 grafts with interstitial  nephritis without rejection  (IN), 2 grafts 
without interstitial  cellular infiltration, and 3 normal donor kidneys (at the time of transplan- 
tation), obtained by percutaneous needle biopsy, surgical biopsy, or nephrectomy for diagnostic 
and therapeutic purposes. Specimens were immersed in isopentane precooled in liquid nitrogen 
and stored at -70°C. With informed consent, 20 ml of heparinized blood was obtained at the 
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time of biopsy in 7 patients (ages 11-54) with suspected rejection and from 12 healthy volunteers 
(ages 23-37). 
Monoclonal Antibodies.  Mouse monoclonal antibodies derived from hybridoma and myeloma 
cell lines were used to define mononuclear cell populations and as controls. The production, 
characterization, specificity,  and source of these antibodies are summarized in Table I. BM11 
is a hybridoma-derived antibody reactive only with human tubular basement membrane and 
Bowman's capsule, which developed after immunization of BALB/c mice with human renal 
basement membrane (A. Michael, unpublished observation). 
Preparation and Staining of Tissue Sections.  Frozen sections (4/lm) of kidney tissue were prepared 
in a Lipshaw cryostat and stored at -70°C. After air drying, sections were acetone-fixed for 10 
rain, washed sequentially three times for a total of 9 min in phosphate-buffered saline (PBS) at 
pH 7.4, overlaid with 20 ~1 of an appropriate dilution of the monoclonal reagent for 30 min, 
and washed briefly with PBS. Slides reacted with mouse monoclonal IgG antibodies were then 
stained with fluorescein isothiocyanate (FITC)-conjugated  F(ab')2 rabbit anti-mouse  IgG (heavy 
and light chains), and those incubated with mouse monoclonal IgM antibodies were stained 
with FITC-labeled F(ab')2 goat anti-mouse IgM (mu chain) (N. L. Cappel Laboratories, Inc., 
Cochranville, Pa.)  for 45 min and then washed with PBS. Amplification was achieved by the 
use of a second FITC-conjugated reagent, either F(ab')2 goat anti-rabbit IgG (heavy and light 
chains) or F(ab')2 rabbit anti-goat IgG (heavy and light chains) (N. L. Cappel Laboratories), 
which were applied as described above. FITC-conjugated F(ab')2 reagents were absorbed with 
human plasma and the optimum dilutions determined by staining  of appropriate animal tissues 
(mouse,  rabbit, or sheep).  After a  final PBS wash, 20 ~1 of ethidium bromide (1:5,000)  was 
applied to stain nuclei (16). 
Standardization of  Monoclonal Reagents and Controls.  The appropriate dilutions  of the monoclonal 
reagents were determined using the amplified immunofluorescence  method described above on 
frozen sections of human spleen, tonsil, thymus, and lymph node. The results of these studies 
were  similar to  previous  reports  (6-9)  of immunofluorescence on  lymphoid  organs  using 
monoclonal reagents.  In  general,  the  optimum concentration of monoclonal antibody for 
staining lymphoid cells  in tissue  was  twice  that  used  for  staining intact mononuclear cells 
isolated from blood. 
TABLE  I 
Source, Subclass, and Specificity of Monoclonal Antibodies 
Monoclonal  Subclass  Specificity  References  antibody 
TA- 1  *  IgG2  T lymphocytes  11 
Monocytes 
OKT3$  IgG2,~  T lymphocytes  10 
OKT4:~  IgG2~,  Helper/inducer  12 
T lymphoeytes 
OKTS~:  IgG~a  Cytotoxic/suppressor  13 
T lymphocytes 
BA-I*  IgM  B lymphocytes; PMN  14 
OKM- 15  IgG2h  Monocytes  15 
Null cells 
UPC 10§  IgG2~  Levan  17 
Inulin 
MOPC 195§  IgG21,  None known  17 
MOPC 104E§  IgM  B1355S  17 
Oextran 
BM 1  l*  IgG2h  Tubular basement membrane  Unpublished 
Bowman's capsule 
* Obtained from the University of Minnesota. 
:l: Obtained from Ortho Pharmaceutical, Raritan, N. J. 
§ Obtained from Litton Binnetics,  Inc., Kensington, Md. JEFFREY  L.  PLATT, TUCKER  W.  LeBIEN, AND ALFRED F.  MICHAEL  19 
The following immunofluorescence controls were used: (a) each tissue was stained with both 
FITC-conjugated F(ab')2 reagents without previous application of the monoclonal antibody; 
(b)  sections of human  spleen, tonsil, and heavily infiltrated transplant kidneys were reacted 
with  serial dilutions of mouse  myeloma-derived Ig of the same subclass as the  hybridoma 
antibodies used in this study (Table I) followed by the two layers of the appropriate FITC- 
conjugated F(ab')2 reagents; and  (c)  a  monoclonal antibody of subclass IgG2b (ascites fluid) 
with  specificity for noncellular elements of human  kidney  (BMll)  was  applied to  heavily 
infiltrated transplant kidneys followed by double layer FITC enhancement. 
Enumeration of Mononuclear Cell Populations in  Tissue.  Sections were examined with a  Zeiss 
universal microscope (Carl Zeiss, Inc., New York) equipped for epifluoreseence with appropriate 
filters and dichroic mirrors through a X63 plan apochromat oil immersion objective and a  10 
×  10-mm ocular indexing grid. The number of positive cells, interstitial cells, and total cells 
(excluding glomeruli and arteries) were counted in each of 30-55  fields, and the percent of 
interstitial  and  total  cells  that  were  positive  was  calculated  for  each  section.  Generally, 
sequential fields were examined in each section, although glomeruli and  large arteries were 
excluded. Cells with a distinctly apple-green fluorescent plasma membrane surrounding a red- 
orange fluorescent nucleus (ethidium bromide) were considered positive. Cells containing no 
nuclear material were rarely observed and were not counted. Also excluded were positive cells 
within  glomeruli, arteries, tubular walls, and  lumina as well as BA-l-positive and  OKMI- 
positive cells having the nuclear or cytoplasmic characteristics of granulocytes. 
Total  and  interstitial  cell  counts  were  performed  using  optics  optimal  for  rhodamine 
immunofluorescence  (546-nm  band  pass  exciter filter, 580-nm  reflector filter, and  LP  590 
barrier filter), and the percent of interstitial cells was calculated according to the expression, 
100  ×  (number  of interstitial cells +  number  of total  cells).  Nuclear  fragments  and  cells 
overlapping the  right and  lower margins of the grid were  not  counted.  The  percentage of 
interstitial cells was also evaluated by examination of companion frozen-sections stained with 
PAS-hematoxylin made in  17 of the 33 tissues. The ratios determined by these two techniques 
were  in  close agreement  with  a  mean  difference of 5.1  +  4.0%  (P >  0.29).  Difficulty in 
distinguishing interstitial cells  from  tubular  cells was  occasionally encountered  in  heavily 
infiltrated tissues, and, therefore, the number of positive cells as a  percent of total cells was 
determined for each tissue as reported herein. 
Preparation,  Staining, and  Enumeration of Blood  Mononuclear Cells.  Mononuclear  cells  were 
separated from whole blood on a conventional Ficoll-Hypaque gradient, suspended in RPMI 
medium,  and  washed  with  medium  consisting of RPMI  and  20%  fetal  horse  serum.  The 
appropriately diluted monoclonal antibody (I00 #1) was added to 100 #1 of cell suspension (107 
cells/ml), incubated at 4°C for 45 min, and washed. 50/zl of FITC F(ab')2 goat anti-mouse IgG 
(Kallestad Laboratories, Inc., Auston, Tex.)  or of FITC F(ab')2 goat anti-mouse IgM (N. L. 
Cappel Laboratories) was added, and the cells were agitated and incubated for 30 min at 4°C. 
The  optimum  dilution  of FITC-labeled  reagents  was  determined  by  staining  of normal 
mononuclear  cell preparations. Cell suspensions were washed  three  times with  RPMI  and 
mounted wet. The number of positive cells per 200 total cells was determined by examination 
of random fields. Control slides were prepared for each specimen as described, omitting addition 
of monoclonal antibody. 
Enumeration of Surface IgD-IgM  (S1teo.M)-positwe Cells.  Tissue sections were  stained with  a 
mixture  at  optimum  end  dilutions of FITC-conjugated F(ab')2 goat  anti-human  IgM  and 
F(ab')2 goat anti-human IgD (N. L. Cappel Laboratories) followed by FITC-conjugated F(ab')2 
rabbit anti-goat IgG (N. L. Cappel Laboratories). Positive cells, interstitial cells, and total cells 
were enumerated with appropriate controls, as described above. 
To  determine  the  relationship of BA-1  positivity to  SIgD,M positivity, human  tonsil and 
transplant kidney sections were each stained sequentially with BA-1, FITC F(ab')2 goat anti- 
mouse  IgM,  FITC  F(ab')2 rabbit  anti-goat  IgG,  and  tetramethylrhodamine  isothiocyanate 
(TRIC)-conjugated F(ab')2 goat anti-human  IgD,M. To exclude binding of the fourth layer 
(goat anti-human IgD,M) to the third layer (rabbit anti-goat IgG), two further controls were 
carried out: (a) goat serum applied after the third layer FITC F(ab')2 rabbit anti-goat IgG did 
not inhibit binding of TRIC F(ab')2 goat anti-human IgD,M;  (b) IgM deposits in sections of 
NZB/NZW mouse kidney identified by FITC F(ab')2 goat anti-mouse IgM followed by FITC 20  INTERSTITIAL CELL  POPULATIONS IN GRAFT REJECTION 
F(ab')2 rabbit anti-goat IgG did not react with TRIC F(ab')2 goat anti-human IgM,D applied 
as a  third layer. The presence of occasional cells in IR tissue positive for BA-1  and negative 
with TRIC F(ab')z goat anti-human IgD,M suggested that the latter did not bind the former. 
Clinical and Histopathologic  Data.  Clinical data were obtained from the medical records of 
each of the patients studied after tabulation of the immunohistochemical analyses. Histopath- 
ological evaluation of each tissue was performed by a pathologist who was neither participating 
in this investigation nor aware of the findings. 
For data analysis, tissues from patients were categorized by pathologic diagnosis based upon 
the clinical picture and morphologic evaluation of the kidney into three groups: (a) renal grafts 
with interstitial rejection (IR); (b) renal grafts with interstitial nephritis not related to rejection 
(IN); and (c) kidneys without interstitial infiltration (two grafts, three normal donor kidneys). 
Group 1 consisted of 22 tissues (tissues 1-22) from 21 patients (10 females, 11 males; ages 4- 
54 yr) with IR. The duration of the graft was 0-4 mo in 13 patients, 4  12 mo in 2 patients, and 
>12  mo  in  6  patients.  The  diseases leading to  renal  failure were  diabetic nephropathy  (8 
patients), chronic glomerulonephritis (6  patients), chronic pyelonephritis (2  patients), reflux 
nephropathy  (2  patients), nephrotic syndrome with  glomerulosclerosis (1  patient), Fabray's 
disease (1 patient), and familial nephritis (1 patient). All patients except one had experienced 
an acute increase in the serum creatinine before percutaneous biopsy (18 patients) or transplant 
nephrectomy (3 patients). The histopathologic diagnoses of these tissues include acute IR (11 
patients), acute  and  chronic  IR  and  vascular rejection  (4  patients), acute  IR  and  vascular 
rejection (4 patients), IR with acute and chronic vascular rejection (1 patient), chronic IR and 
vascular rejection (1 patient), and chronic vascular rejection (1 patient). The latter patient with 
chronic vascular rejection had a clinical course consistent with acute interstitial rejection and 
histologic evidence of substantial interstitial infiltration. Of 17  patients treated for rejection 
after biopsy, 13 experienced improvement of renal function and 4  (all of whom had vascular 
rejection) did not. Two biopsies were performed on one tissue 6 wk and 2 mo after engraftment; 
the first (tissue 20) revealed early acute IR and the second (tissue 21) revealed severe acute IR 
and moderate vascular rejection. Both tissues were studied. 
Group  2  included  6  patients  (tissues 23-28;  3  male,  3  female,  11-41  yr)  with  allografts 
showing IN without clinical or histopathologic evidence of rejection. The diseases leading to 
transplantation were diabetic nephropathy (2 patients), nephrotic syndrome with focal glomer- 
ulosclerosis (3 patients), and chronic glomerulonephritis (1 patient). The grafts had been present 
for 8 d to 7 mo. Three of these patients (tissues 24, 25, and 27) were felt to have cyclosporin A 
toxicity, and  their renal function improved as the dosage of this agent  was decreased. One 
patient (tissue 26) had severe IN of unknown etiology, characterized by interstitial infiltration 
of polymorphonuclear and mononuclear cells without vascular involvement. Improvement in 
renal function occurred without specific therapy. Another patient (tissue 28) had acute tubular 
necrosis 3 wk after transplantation and experienced slow spontaneous improvement. The final 
patient in this group had IN and glomerular exudation with end-stage renal disease (tissue 23). 
A biopsy (tissue 22)  from this patient 2 wk previously revealed prominent interstitial edema, 
modest interstial infiltration, and  normal glomeruli, which,  when  compared to another two 
prior biopsies, was  felt  to  be consistent  with  resolving IR.  Although  rejection might  have 
contributed to the histopathologic findings in tissue 23, the predominam morphologic change 
and the clinical circumstances were those of end-stage renal failure due to recurrence of the 
primary glomerular disease. For these reasons, this tissue is included in group 2. 
Group 3 consisted of tissues lacking interstitial infiltration from a 37-yr-old male (tissue 29) 
who had had chronic glomerulonephritis and had an allograft for 1 mo; from a 27-yr-old female 
(tissue 30)  with diabetes who had been engrafted for  18 too; and from three normal donors 
(tissues 31-33) obtained at the time of transplantation. 
Statistical analysis was performed using Student's t test for dependent or independent means. 
The data given in the text are expressed as mean +  standard deviation (SD). 
Results 
The use of two layers of FITC-labeled F(ab')2 antibody provided sufficient ampli- 
fication  and  duration  of fluorescence to  permit  the counting  of all positive cells in 
each field examined  (Fig.  1).  Plasma membrane staining with TA-1, OKT4, OKT8, JEFFREY  L.  PLATT,  TUCKER  W.  LeBIEN,  AND  ALFRED  F.  MICHAEL  21 
and  BA-1  was  of linear  character  and  uniform  intensity,  with  OKT4  being  the 
weakest. The fluorescence of OKT3- and OKM 1-positive cells varied in intensity and 
was both linear and  granular.  Nuclear staining with ethidium  bromide provided a 
dull orange contrast with the FITC filter system and a brilliant red-orange fluorescence 
with rhodamine filters.  Fine granular BA-I positivity was noted in the cytoplasm but 
not on the plasma membrane of some tubules in most sections. 
Interstitial  Cell Quantitation.  The variability in the number of interstitial  cells  as a 
percent of total cells in sections from each tissue as determined by immunofluorescence 
was relatively low. The percent of interstitial cells  was significantly higher in IR (50 
+  8.2%)  than in the five kidneys-with normal interstitium  (24 +  3.4%, P <  10  -6) but 
was not different from that of grafts with IN (42 +  15%). 
(a)  Positive Cells as Percent  of Interstitial Cells.  In the 22 tissues  with IR, the largest 
FIG.  1.  Photomicrographs of mononuclear cell infiltrates in renal grafts with interstitial rejection 
identified by nuclear staining (A)  and monoclonal antibodies using F(ab')z double fluorochrome 
indirect immunofluorescence (B-F) : (A) ethidium bromide reacting with nuclei of  tubule surrounded 
by cellular infiltrate;  (B) a  T  cell is identified by OKT3 between two segments of tubule (T);  (C) 
two  helper/inducer  cells  are  recognized  by  OKT4  within  the  modestly  enlarged  interstitium 
separating five tubules; (D) nodular accumulation of cytotoxic/suppressor cells stained with OKT8; 
(E) nodular accumulation of B cells stained with BA-I; (F) two cells identified by OKMI antibody 
(monocytes/null cells) surrounded by tubules (out of focus), one of which contains autofluorescent 
granules. Ethidium bromide was not applied to sections B-F. (B, X  1,400; all others, x  590). 22  INTERSTITIAL  CELL  POPULATIONS  IN  GRAFT  REJECTION 
percentage  (35  +  9.8%)  of  interstitial  cells  was  T  cells  (OKT3  positive).  This 
percentage was substantially higher than that observed in three normal donors (3.1- 
3.3%),  two  normal  grafts  (3.3  and  12%),  and  in  grafts with  IN  unassociated  with 
rejection (21  --. 16%, P <  0.02)  (Fig. 2).  In IR, the percent of interstitial cells positive 
for OKT4 (10 ±  5.0%)  was similar to that in IN (15  ±  13%) and the five tissues with 
normal  interstitium  (4.2  ±  3.1%).  In  IR,  however,  the  percent  of OKT8-positive 
interstitial cells (26 ±  7.7%)  was significantly higher than that observed in IN (9.3  + 
6.2%, P <  10  -5)  or in normal kidneys (3.0 ±  2.4%, P <  10-6). 
(b) Positive Cells as Percentage of Total Cells.  The data on individual tissues calculated 
according to the percent of total cells is indicated in Tables II and III. The statistically 
significant differences are similar to those noted above. In each tissue, the percent of 
cells reacting with OKT4 plus OKT8 was approximately equal to OKT3. The mean 
ratio of OKT8/OKT4  in allografts with rejection  (3.2  +  1.4) is strikingly increased 
(P <  0.0007)  when compared with that of kidneys with IN without rejection (0.82 + 
0.39)  or  with  the  two  transplanted  and  three  donor  kidneys  without  interstitial 
infiltration  (0.75  +  0.25)  (Fig. 3). The ratio of OKT8 to total T  cells (OKT3 or TA- 
1) similarly differentiated the groups (P <  0.01). No specific differences were observed 
in the ratios of BA-1 to OKT4, nor in OKM 1 to OKT4, OKT8, OKT3, and BA-1. 
In general, BA-1-positive cells as a percent of total or interstitial cells was low in all 
tissues examined.  The percent of interstitial  or total ceils reactive with OKM1  was 
higher in kidneys with interstitial  infiltration than in those without  infiltration  (P < 
0.02)  (Tables II and III, Fig. 2). 
Focality of Infiltration.  The infiltration of mononuclear cells was focal in all diseased 
tissues studied  but appeared particularly so in acute IR. Nodular accumulations of 
mononuclear cells on most sections consisted mainly of T  cells. Separate and mixed 
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Flo.  2.  Percent of renal interstitial cells identified by mouse monoclonal antibodies reactive with 
T  cells (OKT3), helper/inducer cells (OKT4), cytotoxic/suppressor cells (OKTS),  B cells (BA-I), 
and monocytes and  null cells (OKM1)  in  22  graft  tissues with  interstitial  rejection  (IR),  6  graft 
tissues with  interstitial nephritis (IN)  and 5  other renal tissues that  lacked interstitial infiltration 
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TABLE  II 
Mononuclear Cell Populations of Renal Grafts with Interstitial  Rejection as a Percent of Total Cells 
23 
Tissue  Interstitial 
number*  cells$ 
Interstitial mononuclear cells identified by 
immunofluorescence using monoclonal antibodies 
























%, mean ± SD  % of total cell 
42 ±  6.6  15  1.6  8.3  0.36  6.5 
36 ±  8.1  7.3  2.9  4.4  0.54  t.6 
62 ±  7.1  36  15  20  2.5  17 
55 ±  1.2  23  6.2  19  0.89  8.7 
53 ±  3.9  20  8.9  14  2.2  6.6 
46 ±  2.4  20  6.3  16  0.30  613 
51 +  3.9  13  3.6  10  1.5  4.4 
48 ±  5.4  20  3.0  17  1.l  8.5 
43 +  4.8  13  2.1  10  0.59  2.4 
43 +  5.2  14  3.8  8.9  0.28  4.0 
47 ±  2.9  16  2.3  12  0.23  6.2 
49 +  3.5  15  2.5  13  0.71  7.1 
65 ±  6.9  29  11  26  7.2  5.0 
67 ±  4.6  32  8.0  27  2.7  6.6 
59 +  2.3  24  5.6  19  4.1  10 
42 ±  0.82  11  5.2  6.8  1.1  7.6 
47 5,- 1.9  11  2.7  9.0  0.52  12 
46 +  2.7  13  2.6  9.2  1.2  8.3 
39 +  4.1  iI  3.1  6.7  0.35  5.8 
56 ±  3.6  20  6.2  19  1.5  13 
53 +  2.1  25  4.3  22  0.68  5.5 
49 ±  2.7  12  5.2  11  0.38  2.9 
SD  50+t"8.2  18±7.5  5.1+3.3  14±6.4  1.4±  1.6  7.1+3.6 
* Tissues 20 and 21 were obtained from the same patient. 
$ Interstitial cells as percent of total cells in sections of kidney tissue. 
15),  nodules  of cells principally  reactive  with  BA-1  were  encountered.  In  tissue  15, 
several sections of the nodule were stained with each of the monoclonal reagents, and 
>120  cells were  counted  in  each  field;  50%  were  positive  for  BA-1,  33%  for  TA-1, 
37%  for OKT3,  13%  for OKT4,  19%  for OKT8,  and  3%  for OKM1.  The  percent  of 
BA-l-positive cells was approximately  equivalent  to  the percent  of cells shown  to be 
SIgM,D+. 
Peripheral Blood Mononuclear Cell Populations.  Comparison of blood mononuclear cell 
populations  in  7  patients  with  IR  to  those  of  12  controls  demonstrates  a  similar 
percent  of cells in  each  group  reacting  with  OKT8  and  BA-1  (Table  IV).  Allograft 
recipients  had  fewer  OKT4-positive  (P  =  0.001)  and  more  OKMl-positive  (P  < 
0.001)  cells than controls. The ratio of OKT8/OKT4-positive  cells in kidney exceeded 
that  present  in the blood in five of six determinations,  the only exception  (patient  17) 
being a  patient  who had  received intensive therapy  for rejection for 2 d  before biopsy 
(Table V). 
Specificty of Monoclonal Antibody Reactivity.  To confirm the specificity of monoclonal 
antibodies  for human  T  and  B  cells, two monoclonal antibodies reactive with T  cells 
were used  (TA- 1 and OKT3).  The number  of cells as a  percent  of total cells reacting 
with TA-1 and OKT3  was  20 ±  9.6 and  18.2  +  7.5, respectively in IR; 5.8 ±  2.8 and 
6.1  ±  4,6 in IN; and 0.88  +  0.38  and 0.78  ±  0.04 in uninfihrated  kidney  tissue, 24  INTERSTITIAL CEI,L  POPULATIONS  IN GRAFT  REJECTION 
TABLE  III 
Mononuclear  Cell Populations of Renal Grafts without Rejection and Normal Donor Kidneys as a Percent  of 
Total Cells 
Tissue  Interstitial 
number*  cells:[: 
Interstitial mononuclear cells identified by immunofluorescence using 
monoclonal antibodies 
OKT3  OKT4  OKT8  BA- 1  OKM 1 
Grafts with interstitial 
nephritis other than rejection  % of total cells 
%, mean + SD 
23  47 4- 3.7  t3  5.2  7.5  0.27  7.3 
24  30 +  3.7  2.9  2.1  2.0  0.78  3.3 
25  31 +  4.3  1.2  0.83  0.92  0.06  1.3 
26  69 4- 6.6  30§  24  12  2.2  16 
27  36 4- 5.0  6.8  5.0  2.3  0.07  1.5 
28  38 +  3.7  6.8  4.8  2.4  0.08  11 
Mean 4- SD  424-  15  10-  11  7.0+8.5  4.54-4.3  0.584-0.84  6.74-5.9 
Tissues without interstitial 
infiltrates 
Renal grafts 
29  30 ___ 2.9  3.3§  2.9  2.3  0  5.0 
30  23 __. 1.8  0.80  0.66  0.66  0.48  1.7 
Donor tissue 
31  21 4- 1.9  0.78  0.55  0.34  0  0.66 
32  24 _+ 2.7  0.73  0.94  0.37  0.13  0.43 
33  23 + 2.1  0.83  0.33  0.3 i  0  0.87 
Mean+SD  244-3.4  1.34-  1.1  1.I+  1.0  0.80+0.85  0.124-0.21  1.74-  1.9 
* Tissues 22 (see Table II) and 23 were obtained from the same patient. 
:~ Interstitial cells as percent of total cells in sections of kidney. 
§ TA-1 value given, OKT3 not done. 
Comparison  of the percent  BA-1-positive cells with  the percent  of cells with SIgD,M 
reactivity  was  carried  out  in  seven  renal  grafts  with  IR,  five  grafts  with  IN,  one 
normal transplant  and  one donor biopsy.  In these  14 tissues,  the percent  of total cells 
that  were BA-1  positive was 0.96  ±  0.80, whereas  the percent  of cells with SIgD,M was 
1.2  ±  1.0.  Dual  label staining  for BA-1  (FITC)  and  SIgD,M (TRIC)  revealed that  cells 
positive for the former were also positive for the latter. 
Fc Receptor  Binding  Controls.  Mouse  myeloma-derived  IgG2a,  IgGzb, and  IgM  were 
applied  to  normal  human  spleen  and  transplant  kidney  tissue  followed by  a  double 
layer of FITC-conjugated  F(ab')z  reagents.  At  dilutions  of mouse  Ig similar to  those 
used  with  hybridoma-derived  reagents  (mg/ml),  no  cell  membrane  staining  was 
observed.  At  concentrations  of myeloma  proteins  20-100-fold  higher  than  those  at 
which  hybridoma  antibodies  were used,  occasionally very weakly staining  cells were 
noted.  Because OKT4-positive  cells at  times stain weakly, we used  a  second control; 
a  hybridoma-derived  mouse  IgGzb  antibody  with  specificity  for  human  Bowman's 
capsule and tubular basement membrane  was applied in excess to transplant  rejection 
tissue at various dilutions  followed by a  double  fluorochrome layer. At no concentra- 
tion of this antibody  was cell membrane  positivity noted,  whereas  tubular  basement 
membranes  and  Bowman's capsule stained  intensely at  all concentrations. 
Clinical  Correlations.  In  interstitial  rejection,  no  relationship  was  evident  between 
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Fro.  3.  Ratio of percent of total cells reactive wtih OKT8 antibody to percent of total cells reactive 
with  OKT4 antibody  in  22  renal  graft  tissues  with  interstitial  rejection  (IR)  and  in  11  tissues 
without rejection:  6 grafts  with interstitial nephritis (IN) and 5 tissues (from 2 grafts  and 3 donor 
kidneys) without interstitial infiltration (C)). P <  10  -5, 
TABLE  IV 
Mononuclear Cell Populations  in Blood of Seven Patients with Interstitial Rejection 
Percent  of mononuclear cells identified by immunofluorescenee using  Number of  mononuclear antibodies (mean ±  SD)  patients and 
controls  TA- 1  OKT3  OKT4  OKT8  BA- 1  OKM 1 
Interstitial  7  58-#-20  48±22  24+  13"  21 +  17  16±  10  30__. 11 
rejection 
Controls  12  68+  14  66±  10  45±  11  19±3.5  13±5.9  11 ±7.1 
* P< 0.001. 
of rejection, the histopathologic  type of rejection,  the longevity of the graft,  and  the 
response  to therapy. 
In two instances serial biopsies were examined.  Tissue 20, with early acute IR, was 
obtained  2  wk  before  tissue  21,  with  severe  acute  IR  and  vascular  rejection.  Only 
minimum  differences in mononuclear  cells were observed between the two specimens, 
although the OKT8/OKT4  ratio changed  from 3.1  to 5.1. The second patient  (tissues 
22 and  23)  had  resolving acute IR  1 mo after transplantation  and  2  wk later had  IN 
with  end-stage  renal  failure  from  recurrence  of  original  disease.  Changes  in  the 
interstitial  cell populations  in  this  kidney  were characterized  by  a  slight  increase  in 26  INTERSTITIAL CELL  POPULATIONS  IN  GRAFT  REJECTION 
TABLE  V 
Comparison of the Ratios of OKTS/ OKT4 in Blood and Renal Interstitium of 
Seven Patients with Interstitial Rejection 
Tissue number 
OKT8/OKT4 Ratio 
Blood  Kidney 
Interstitial rejection 
4  0.71  3.2 
12  0.50  4.3 
i5  0.43  3.2 
16  0.38  1.4 
17  6.5  3.0 
18  2.0  3.O 
19  0.47  2.3 
Normal controls  0.43  +  0.14  (12)*  0.75 +- 0.25  (5)* 
* The  number in  parentheses indicates  the  number evaluated.  Controls for 
blood  include  12  healthy  volunteers and  for  kidney  the  5  kidney  tissues 
without interstitial  infiltrate  (3 donor kidneys, 2 grafts). The mean +  SD is 
indicated. 
OKM 1-positive cells and a decrease in OKT8-reactive cells. The OKT8/OKT4  ratios 
in the two tissues were 2.1  and  1.4, respectively. 
Discussion 
The introduction  of monoclonal antibodies  with  specificity for cell surface deter- 
minants of various mononuclear cells has spurred  investigation  of peripheral  blood 
cell  populations  in  a  number of diseases,  including  leukemia  (18),  lymphoma (19), 
infectious mononucleosis (20), and interstitial nephritis (21).  The application of these 
antibodies  to tissues has helped  define the cellular constituents of several lymphoid 
organs  (6-9).  However, more extensive immunohistologic use has been hindered  by 
weak fluorescence using conventional  indirect  staining  (9).  In this study,  we  found 
that double fluorochrome amplification with F(ab')2 reagents and counterstaining of 
nuclei allowed quantitation of cell populations in frozen sections of tissue. 
Of  identifiable  interstitial  ceils  in  22  tissues  from  21  renal  grafts  undergoing 
rejection, T  cells were most numerous,  and the greater fraction of these were OKT8 
positive. The mononuclear cell infiltrates of grafted kidneys with IN also contained a 
preponderance of T  cells; however, the OKT8-positive fraction was significantly less 
than  in  IR, and, as a  consequence,  the OKT8/OKT4  ratio was significantly lower. 
Indeed, the only tissue in the IN group whose OKTS/OKT4  ratio overlapped those 
of the  rejection  group  was  tissue  23,  whose  group  designation  was  most  difficult. 
Monocytes and  null  cells  (defined  by monoclonal  antibody  OKM1)  represented  a 
substantial and approximately equal proportion of infiltrating cells in both types of 
interstitial  disease. B cells did not account for >10% of interstitial cells in any tissue 
studied and did not distinguish IR from IN. 
T  cell populations were enumerated with OKT3 and TA-1  antibodies. The latter 
reagent reacts with T  cells and monocytes (11)  and may recognize natural killer cells 
and ~ 10% less than the sum of OKT4- and OKT8-positive cells in blood (T. LeBien, 
unpublished  observations). The similar range of interstitial cells reacting with TA-1 
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the  proportions  of T  cells  present  in  the  tissues  examined.  Confirmation  of BA-1 
reactivity for B cells in tissue is suggested by the similar percentages of cells having 
SXgD,M reactivity.  By  staining  tissue  with  both  BA-1  and  F(ab  ~)  goat  anti-human 
IgD,M, the overlapping specificities of these reagents was confirmed. 
Although  the  functional  correlates  of blood  cells  reacting  with  OKT3,  OKT4, 
OKT8, OKM 1, and BA-1 are well defined, there is no certainty that these apply to 
cells in tissue.  However, studies of cell suspensions made from lymphoid organs (22) 
and  transplant  kidneys  (23)  suggest  that  some  T  and  B  cell  properties  in  tissue 
resemble  those  in  blood.  Furthermore,  the  paucity  of positive  cells  in  donor  and 
histologically normal  transplant  tissue  sections suggests  that  the  specificities of the 
antibodies used is not broader in tissue than in blood. In this regard, it is reasonable 
to ask whether substantial numbers ofT cells in the kidney may express determinants 
recognized by both OKT4 and OKT8, thus beguiling attempts to use a  ratio of the 
two.  The data  of this  study  tend  to  oppose such  a  hypothesis  because  the  sum  of 
OKT4 and OKT8 usually approached that of OKT3 or TA- 1. 
Others  have found  (4,  5)  larger numbers of B  cells  in  renal  transplant  rejection 
tissue than our investigation revealed. However, the differences may be methodologic. 
These  studies  were  performed  on  cell  suspensions  made  from  tissue  obtained  at 
transplant  nephrectomy,  whereas  only  three of the  tissues  examined  for our study 
were obtained from irreversibly rejected kidneys. The mean percent of interstitial  B 
cells in these three kidneys, though low (5.3%), was twice that of the IR group mean. 
Further, it has been shown that by 96 h  after pokeweed mitogen stimulation, 80% of 
B  cells lose  BA-1  positivity  (14).  Because neither  these  cells  nor plasma cells react 
notably  with  BA-1,  it  is  possible  that  activated  Sig+  B  cells  may  account  for  the 
apparent low percentage of recognizable B cells. Still, most in vitro activated B cells 
react with anti-human  IgM antiserum  (22).  It is possible that  there are substantial 
numbers of activated Sigo+ SISM.D- cells in transplant kidneys. However, in blood (24), 
spleen  (25),  and  activated  lymphoid  tissue  (22)  these  cells  represent  only  a  small 
proportion of Sig+ cells. Further, our method of counting interstitial cells includes all 
cells  not  attached  to  tubules,  arteries,  and  glomeruli.  Thus,  our definition  is  more 
inclusive  than  that  of other  investigators.  If one  applies  data  obtained  from  the 
normal kidney tissue examined, a significant percentage of the interstitial cells counted 
in the rejection group may be normal tissue elements. To these nonreactive cells must 
be added plasma cells, some null cells, PMN, eosinophils, and mast cells, which were 
not  enumerated.  Further,  the  aggregate  percent  of  interstitial  cells  identified  by 
monoclonal antibodies in IR tissue exceeded those in IN by -10%. Lastly, the process 
of harvesting mononuclear cells from tissue, as performed in other studies, results in 
the selective loss of some cell populations  and enrichment  of others  (23,  26).  Thus, 
results obtained by analysis of cell suspensions and tissue sections may differ (27). 
No systematic attempt was made to survey all types of interstitial nephritis in the 
transplant kidney nor to examine tissue that had infiltration comparable with that of 
the transplant  group. The percentage of total cells located in the interstitium  of IR 
tissue was not significantly different from that in IN, although the mean of the former 
exceeded that of the latter by ~ 15%. Further,  there was no correlation between the 
OKT8/OKT4  ratio and degree of tissue infiltration.  Indeed, it was the type of cells 
rather than the number of cells that best distinguished  these two groups. 
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antibodies  did  not  appear  to  distinguish  acute  from  chronic  nor  vascular  from 
interstitial rejection. In addition, there appeared to be no correlation with severity. 
On the other hand, in the two instances in which serial biopsies were examined, the 
progression of rejection was  accompanied by an  increasing ratio of OKT8/OKT4 
and resolution by a decreasing ratio. This relationship warrants further investigation. 
The  mononuclear blood cell  populations  of seven patients  undergoing  rejection 
appeared to have a smaller proportion of cells reactive with OKT3 and OKT4 and 
a greater proportion of cells reactive with OKM 1 than did normal controls. However, 
the proportions ranged broadly in the patients with allograft rejection, and specific 
values did not appear to correlate with the relative percentages of mononuclear cells 
in  corresponding kidney  tissue  nor with  consistent  increase  in  OKT8  cells.  These 
results are consistent with previous observations demonstrating a  much higher per- 
centage of cytotoxic cells derived from rejecting kidneys than from peripheral blood 
(2). 
There is evidence (28)  suggesting that  the proportions of peripheral blood T  cell 
subsets  may define groups of allograft recipients at low and  high risk for rejection. 
The T  cell data reported herein were determined on blood obtained at the time of 
allograft biopsy in consecutive unselected patients with established rejection and thus 
are not completely comparable with this report. 
Renal allograft rejection would appear to be characterized by interstitial infiltration 
consisting primarily of T  cells, the majority of which have determinants recognized 
by OKT8. These OKT8 cells may have importance in  the mediation of transplant 
rejection. 
Summary 
The  interstitial  mononuclear cell populations  of 22  renal  grafts with  interstitial 
rejection (IR), 6 grafts with interstitial nephritis without rejection (IN), and 5 kidneys 
without  infiltration  (3  donor kidneys, 2  grafts)  were identified and  quantitated  by 
monoclonal  antibodies  recognizing  T  cells  (TA-1,  OKT3),  helper  inducer  cells 
(OKT4), cytotoxic/suppressor cells (OKT8), B cells (BA-1), and monocytes and null 
cells  (OKM1).  Double-layer fluorochrome enhancement using F(ab')z reagents and 
nuclear counter staining with ethidium bromide enabled quantitation of the number 
of positive  mononuclear  cells,  interstitial  cells,  and  total  cells  on  each  of 30-55 
microscopic fields per tissue section. T  cells were the most abundant  infiltrating cell 
in tissues with IR (35  ±  9.8%), significantly higher than that seen in IN (21  ±  16%) 
or in kidneys without infiltration (5.0 ±  3.9%). The percentage ofT cells identified by 
TA-1  or  OKT3  was  approximately  equivalent  to  the  summation  of OKT4  plus 
OKT8. Although no differences were observed in the percentage of OKT4 cells, the 
percentage of OKT8 was significantly higher in IR (26 ±  7.7%, P<  10  -4) than in IN 
(9.3 +_. 6.2%) or in kidneys with normal interstitium (3.0 ±  2.4%). The ratio of OKT8/ 
OKT4-positive T  cells in 22 graft tissues with IR (3.2 +  1.4) was greater (P <  0.0007) 
than 6 graft tissues with IN without rejection (0.82 ±  0.39)  and the 5 kidney tissues 
without  interstitial  infiltration  (0.75  ±  0.25).  There  was  no  significant  difference 
between the groups in the relatively low percentage of interstitial cells identified as B 
cells  reacting  with  BA-1  or  containing  SIgD,M. The  percentage  of interstitial  cells 
recognized by OKM1  was  similar  in  rejection and  interstitial  nephritis,  with  both 
being greater than controls (P <  0.02). The relative numbers of blood mononuclear JEFFREY  L.  PLATT, TUCKER W.  LeBIEN, AND ALFRED F.  MICHAEL  29 
cells  identified  by  the  monoclonal  antibodies  was  generally  not  predictive  of the 
proportions  present  in  kidney  tissue,  although  OKT4-positive  blood  cells  were  less 
numerous and OKMI+  blood cells were more numerous than in controls (P <  0.002). 
Quantitative  analysis of identifiable  interstitial  cells in graft rejection reveals that 
most infiltrating  cells are T  cells, the greater proportion of which are recognized by 
OKT8.  OKTS-positive  cells  may play  an  important  role  in  mediating  renal  graft 
rejection. 
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